UBS Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.9M | Buy |
346,400
+30,700
| +10% | +$2.36M | ﹤0.01% | 2356 |
|
|
2025
Q4 | $25.1M | Sell |
315,700
-135,000
| -30% | -$10.6M | ﹤0.01% | 2365 |
|
|
2025
Q3 | $34M | Buy |
450,700
+238,600
| +112% | +$16.4M | 0.01% | 2018 |
|
|
2025
Q2 | $14.6M | Buy |
212,100
+10,000
| +5% | +$656K | ﹤0.01% | 2701 |
|
|
2025
Q1 | $13.7M | Sell |
202,100
-79,000
| -28% | -$4.73M | ﹤0.01% | 2729 |
|
|
2024
Q4 | $12.6M | Buy |
281,100
+46,300
| +20% | +$2.6M | ﹤0.01% | 2808 |
|
|
2024
Q3 | $14.8M | Buy |
234,800
+2,500
| +1% | +$146K | ﹤0.01% | 2064 |
|
|
2024
Q2 | $13.7M | Sell |
232,300
-10,000
| -4% | -$626K | ﹤0.01% | 1982 |
|
|
2024
Q1 | $19.3M | Sell |
242,300
-603,900
| -71% | -$46.1M | ﹤0.01% | 1724 |
|
|
2023
Q4 | $66.8M | Buy |
846,200
+104,800
| +14% | +$7.46M | 0.02% | 797 |
|
|
2023
Q3 | $51.8M | Sell |
741,400
-15,000
| -2% | -$1.06M | 0.02% | 832 |
|
|
2023
Q2 | $52.3M | Sell |
756,400
-229,000
| -23% | -$16.3M | 0.02% | 808 |
|
|
2023
Q1 | $73.2M | Sell |
985,400
-369,800
| -27% | -$31M | 0.03% | 584 |
|
|
2022
Q4 | $126M | Buy |
1,355,200
+118,100
| +10% | +$11.4M | 0.05% | 407 |
|
|
2022
Q3 | $118M | Buy |
1,237,100
+210,100
| +20% | +$20.8M | 0.05% | 367 |
|
|
2022
Q2 | $95.2M | Sell |
1,027,000
-1,111,500
| -52% | -$108M | 0.04% | 463 |
|
|
2022
Q1 | $216M | Sell |
2,138,500
-777,400
| -27% | -$81.7M | 0.07% | 273 |
|
|
2021
Q4 | $301M | Buy |
2,915,900
+1,844,048
| +172% | +$170M | 0.09% | 231 |
|
|
2021
Q3 | $91M | Sell |
1,071,852
-80,500
| -7% | -$6.74M | 0.03% | 570 |
|
|
2021
Q2 | $96.2M | Buy |
1,152,352
+265,497
| +30% | +$21.7M | 0.03% | 535 |
|
|
2021
Q1 | $66.7M | Buy |
886,855
+198,155
| +29% | +$14.4M | 0.02% | 679 |
|
|
2020
Q4 | $47M | Buy |
688,700
+91,200
| +15% | +$5.93M | 0.02% | 815 |
|
|
2020
Q3 | $34.9M | Sell |
597,500
-780,520
| -57% | -$48.6M | 0.01% | 843 |
|
|
2020
Q2 | $89.5M | Buy |
1,378,020
+569,120
| +70% | +$35.8M | 0.04% | 405 |
|
|
2020
Q1 | $48M | Sell |
808,900
-83,000
| -9% | -$5.54M | 0.02% | 560 |
|
|
2019
Q4 | $66.3M | Buy |
891,900
+75,500
| +9% | +$5.3M | 0.02% | 613 |
|
|
2019
Q3 | $51.5M | Buy |
816,400
+10,600
| +1% | +$628K | 0.02% | 681 |
|
|
2019
Q2 | $43.9M | Buy |
805,800
+465,400
| +137% | +$25.1M | 0.02% | 730 |
|
|
2019
Q1 | $18.4M | Buy |
340,400
+200,000
| +142% | +$12.3M | 0.01% | 1195 |
|
|
2018
Q4 | $9.2M | Buy |
140,400
+24,200
| +21% | +$1.81M | ﹤0.01% | 1640 |
|
|
2018
Q3 | $9.15M | Sell |
116,200
-194,700
| -63% | -$13.9M | ﹤0.01% | 1852 |
|
|
2018
Q2 | $20M | Buy |
310,900
+62,800
| +25% | +$4.14M | 0.01% | 1172 |
|
|
2018
Q1 | $15.4M | Sell |
248,100
-1,797,100
| -88% | -$129M | 0.01% | 1338 |
|
|
2017
Q4 | $148M | Buy |
2,045,200
+1,920,600
| +1,541% | +$140M | 0.06% | 303 |
|
|
2017
Q3 | $10.1M | Buy |
124,600
+124,200
| +31,050% | +$9.82M | ﹤0.01% | 1610 |
|
|
2017
Q2 | $32K | Sell |
400
-131,000
| -100% | -$10.3M | ﹤0.01% | 5979 |
|
|
2017
Q1 | $10.3M | Sell |
131,400
-49,200
| -27% | -$3.93M | 0.01% | 1469 |
|
|
2016
Q4 | $14.3M | Buy |
180,600
+131,200
| +266% | +$10.6M | 0.01% | 1251 |
|
|
2016
Q3 | $4.4M | Sell |
49,400
-34,700
| -41% | -$3.28M | ﹤0.01% | 2136 |
|
|
2016
Q2 | $8.05M | Hold |
84,100
| – | – | 0.01% | 1551 |
|
|
2016
Q1 | $8.72M | Sell |
84,100
-90,900
| -52% | -$8.84M | 0.01% | 1428 |
|
|
2015
Q4 | $17.1M | Buy |
175,000
+99,100
| +131% | +$9.71M | 0.01% | 1040 |
|
|
2015
Q3 | $7.32M | Sell |
75,900
-400
| -0.5% | -$42.1K | 0.01% | 1617 |
|
|
2015
Q2 | $8M | Sell |
76,300
-6,000
| -7% | -$613K | 0.01% | 1648 |
|
|
2015
Q1 | $8.49M | Buy |
82,300
+1,600
| +2% | +$162K | 0.01% | 1599 |
|
|
2014
Q4 | $7.77M | Buy |
+80,700
| New | +$7.11M | 0.01% | 1704 |
|
Other funds holding CVS
VCM
VPM
UBS Group's CVS Position: Q1 2026 in Review
UBS Group reduced its CVS Health (CVS) stake by 7.5% in Q1 2026, selling an estimated $38.4M and leaving 6,130,298 shares worth $440M. The position accounts for 0.07% of the portfolio, ranked #298.
UBS Group first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $942M in Q3 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- UBS Group held 6,130,298 shares of CVS Health worth $440M as of Q1 2026.
- UBS Group sold 498,915 CVS Health shares in Q1 2026, an estimated $38.4M.
- CVS Health made up 0.07% of UBS Group's portfolio in Q1 2026, its #298 holding.
- UBS Group first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
- UBS Group's CVS Health position peaked at $942M in Q3 2017.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.